Allurion Technologies (ALURW) Income from Continuing Operations (2022 - 2026)
Allurion Technologies (ALURW) reported Income from Continuing Operations of 6095000.0 for Q1 2026, down 306.06% on a YoY basis from 2957838.67 in Q1 2025, and down 126.48% quarter-over-quarter from 23020000.0 in Q4 2025.
Allurion Technologies (ALURW) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Allurion Technologies has reported Income from Continuing Operations for 5 years, with the latest figure at 6095000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 306.06% year-over-year to 6095000.0; the trailing twelve-month figure through Mar 2026 stood at 4294000.0 (down 24.5% YoY), and the FY2025 full-year result was 347000.0, up 179.84% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 6095000.0, down from 23020000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 62043000.0 in Q4 2023, with the low at 21996000.0 in Q2 2023.
- Historically, Income from Continuing Operations has averaged 115875.0 across 5 years, with a median of 5750000.0 in 2022.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations sank 306.96% — and 2025, when it surged 1102.61%.
- Allurion Technologies' Income from Continuing Operations stood at 25962000.0 in 2022, then soared by 138.98% to 62043000.0 in 2023, then tumbled by 103.7% to 2296000.0 in 2024, then surged by 1102.61% to 23020000.0 in 2025, then tumbled by 126.48% to 6095000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 6095000.0 (Q1 2026), 23020000.0 (Q4 2025), and 11884000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | -6.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | 23.02 Mn |
| Sep 30, 2025 | -11.88 Mn |
| Jun 30, 2025 | -9.34 Mn |
| Mar 31, 2025 | -1.50 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -8.36 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 62.04 Mn |
| Sep 30, 2023 | -21.63 Mn |
| Jun 30, 2023 | -22.00 Mn |
| Mar 31, 2023 | -17.80 Mn |
| Dec 31, 2022 | 25.96 Mn |
| Sep 30, 2022 | -13.57 Mn |
| Jun 30, 2022 | -5.41 Mn |